60 Degrees Pharmaceuticals
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$9,201general payments (2019-2025)
$0.00research payments (2019-2025)
22clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Shannon Delaney | New York, NY | Child & Adolescent Psychiatry | $1,786.10 |
| Thomas Moorcroft | Hebron, CT | Family Medicine | $1,356.10 |
| Denis Bouboulis | Darien, CT | Allergy & Immunology | $986.10 |
| Virginia Savely | Bethesda, MD | Family | $986.10 |
| Richard Horowitz | Hyde Park, NY | Internal Medicine | $986.10 |
| Leo Galland | New York, NY | Internal Medicine | $800.00 |
| Luis Marcos | New York, NY | Psychiatry | $800.00 |
| Laura Kirkman | New York, NY | Infectious Disease | $800.00 |
| Tania Dempsey | White Plains, NY | Internal Medicine | $70.00 |
| Casey Kelley | Chicago, IL | Family Medicine | $70.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.